Latest Breaking News On - Biocity nottingham - Page 1 : vimarsana.com

​Property podcast: Life sciences titans We Are Pioneer Group and JLL discuss landmark new report

​Property podcast: Life sciences titans We Are Pioneer Group and JLL discuss landmark new report

Alderley Park 'will remain flagship bioscience location'

Alderley Park will remain flagship bioscience location Manchester Science Parks takes over former AstraZeneca site A long chapter in the UK s pharmaceutical history came to a close yesterday with the sale of AstraZeneca s 400-acre Alderley Park site in Cheshire. The new owners of the site - Manchester Science Parks (MSP) - have pledged to maintain and expand Alderley Park as a leading UK incubator for life sciences businesses. MSP will build on Alderley Park s heritage of scientific innovation, said AZ in a statement. The company said last year that it planned to cut about 1,600 jobs as part of an overhaul of its R&D operations, with 600 jobs lost in Cheshire, and would also relocate its global corporate headquarters to Cambridge by 2016.

How Nottingham could become 'Silicon Valley of the Midlands'

How Nottingham could become Silicon Valley of the Midlands For a city of its size, Nottingham punches above its weight 04:00, 8 APR 2021 Nottingham city centre. (Image: Nottingham & Derby Hot Air Balloon Club Robin Macey.) Never miss another Nottinghamshire story by signing up to our free email updatesInvalid EmailSomething went wrong, please try again later. Subscribe When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.

Investegate |Remote Monitored Sys Announcements | Remote Monitored Sys: Notice of General Meeting

1.00 p.m. on 10 February 2021 Date and time of General Meeting 1.00 p.m. on 12 February 2021   1.  Introduction Authority to issue the Warrants On 18 December 2020, the Company announced that it had raised gross proceeds of £5,000,000 through an oversubscribed placing of 400,000,000 new Ordinary Shares (the Placing Shares ) at a price of 1.25 pence per Placing Share (the Placing ). The Placing Shares commenced trading on AIM on 23 December 2020. For each Placing Share subscribed for, each investor participating in the Placing is entitled to receive one non-transferrable warrant to subscribe for an Ordinary Share with an exercise period of 3 months from its issuance (subject to any extension) and exercisable at a price of 2 pence per Ordinary Share (the Placing Warrants ).